A Trail of Sperstent® Used for Residual Lesions of Femoropopliteal Arteries

NARecruitingINTERVENTIONAL
Enrollment

240

Participants

Timeline

Start Date

June 4, 2024

Primary Completion Date

December 4, 2026

Study Completion Date

December 31, 2026

Conditions
Peripheral Arterial DiseaseStenosisDissection
Interventions
DEVICE

Sperstent® peripheral spot stent system

Sperstent® peripheral spot stent system, Percutaneous Transluminal Angioplasty (PTA), Digital Subtraction Angiography(DSA)

DEVICE

Everflex® self-expanding peripheral stent system

Everflex® self-expanding peripheral stent system, Percutaneous Transluminal Angioplasty (PTA), Digital Subtraction Angiography(DSA)

Trial Locations (12)

Unknown

NOT_YET_RECRUITING

Beijing Friendship Hospital, Capital Medical University, Beijing

NOT_YET_RECRUITING

The First Affiliated Hospital of Chongqing Medical University, Chongqing

NOT_YET_RECRUITING

The Second Hospital of Hebei Medical University, Shijiazhuang

NOT_YET_RECRUITING

First Affiliated Hospital of Zhengzhou University, Zhengzhou

RECRUITING

Liyuan Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan

RECRUITING

Nanjing Drum Tower Hospital, Nanjing

NOT_YET_RECRUITING

Affiliated Hospital of Nantong University, Nantong

NOT_YET_RECRUITING

Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai

NOT_YET_RECRUITING

The Affiliated Hospital of Southwest Medical University, Luzhou

NOT_YET_RECRUITING

The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou

NOT_YET_RECRUITING

Hospital of Chengdu University of TCM, Chengdu

RECRUITING

Shanghai East Hospital, Shanghai

All Listed Sponsors
lead

FrontAce Scientific Co., Ltd

INDUSTRY